Production (Stage)
Bio-Techne Corporation
TECH
$46.78
-$0.54-1.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -35.26% | 3.84% | -17.22% | -17.27% | 78.61% |
| Total Depreciation and Amortization | 1.80% | -3.74% | 251.74% | -167.90% | -1.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -66.10% | -14.40% | -30.42% | 419.99% | -63.77% |
| Change in Net Operating Assets | -202.41% | 225.24% | 4.87% | -869.05% | -92.91% |
| Cash from Operations | -51.25% | 32.02% | -15.37% | -6.78% | -2.56% |
| Capital Expenditure | -48.41% | 25.63% | 48.99% | -9.36% | -10.61% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | -236.42% | -- | 100.00% |
| Cash from Investing | -76.33% | 76.79% | -146.19% | 46.43% | 30.54% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | 100.00% | 72.86% | -20.69% | 0.00% |
| Issuance of Common Stock | 168.45% | -77.93% | 9.45% | 25.11% | 247.44% |
| Repurchase of Common Stock | -30.92% | -1,437.74% | -1,139.80% | -139.29% | 99.79% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.22% | -0.38% | -0.48% | -0.38% | -0.16% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 18.84% | -624.54% | 80.75% | -14.65% | 35.61% |
| Foreign Exchange rate Adjustments | 80.23% | -206.90% | -3.18% | 325.19% | -168.54% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -269.12% | -127.95% | 201.02% | 21.39% | 152.79% |